Asarina Pharma AB (FRA:APS) Other Income (Expense) : €-0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Asarina Pharma AB Other Income (Expense)?

Asarina Pharma AB's other income expense for the Asarina Pharma AB's pretax income for the three months ended in Jun. 2023 was €0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.00 Mil.

Asarina Pharma AB Other Income (Expense) Historical Data

The historical data trend for Asarina Pharma AB's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asarina Pharma AB Other Income (Expense) Chart

Asarina Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Income (Expense)

Get a 7-Day Free Trial

0.01

0.25

-0.14

0.04

0.01

Asarina Pharma AB Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
Other Income (Expense)	Get a 7-Day Free Trial															0.04	-	-	-	-

Asarina Pharma AB Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00 Mil.

Asarina Pharma AB (FRA:APS) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Asarina Pharma AB (FRA:APS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (FRA:APS) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

ASAP:Sweden

Address

Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65

Website

https://www.asarinapharma.com

Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB (FRA:APS) Headlines

No Headlines